uniQure (QURE) Acquisitions (2022)
uniQure's (QURE) quarterly Acquisitions came in at $1.1 million in Q3 2022, up 31.14% quarter-over-quarter from $822000.0 in Q1 2022.
uniQure (QURE) Acquisitions (2022) Analysis & Trends
uniQure's Acquisitions history runs 1 years deep, the most recent figure standing at $1.1 million for Q3 2022.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $1.1 million in Q3 2022; TTM through Dec 2022 was $1.9 million, a N/A change from a year earlier, with the FY2022 full-year figure at $1.9 million, down 96.2% from the prior year.
- Acquisitions improved to $1.1 million in Q3 2022 per QURE's latest filing, from $822000.0 in the prior quarter.
- Across five years, Acquisitions topped out at $1.1 million in Q3 2022 and bottomed at $822000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 822,000.00 |